Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON58938Phase 1Completed
Phase 1, open-label, single-arm trial of RO7268489, sponsored by Roche. Started Jun 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON58938.